Structure

Physi-Chem Properties

Molecular Weight:  608.17
Volume:  560.823
LogP:  1.031
LogD:  0.104
LogS:  -3.753
# Rotatable Bonds:  7
TPSA:  238.2
# H-Bond Aceptor:  15
# H-Bond Donor:  8
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.159
Synthetic Accessibility Score:  4.672
Fsp3:  0.464
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.43
MDCK Permeability:  4.3530242692213506e-05
Pgp-inhibitor:  0.007
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.9
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.074
Plasma Protein Binding (PPB):  78.67637634277344%
Volume Distribution (VD):  0.622
Pgp-substrate:  15.294493675231934%

ADMET: Metabolism

CYP1A2-inhibitor:  0.084
CYP1A2-substrate:  0.144
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.068
CYP2C9-inhibitor:  0.008
CYP2C9-substrate:  0.21
CYP2D6-inhibitor:  0.037
CYP2D6-substrate:  0.197
CYP3A4-inhibitor:  0.033
CYP3A4-substrate:  0.015

ADMET: Excretion

Clearance (CL):  1.516
Half-life (T1/2):  0.615

ADMET: Toxicity

hERG Blockers:  0.298
Human Hepatotoxicity (H-HT):  0.101
Drug-inuced Liver Injury (DILI):  0.936
AMES Toxicity:  0.737
Rat Oral Acute Toxicity:  0.018
Maximum Recommended Daily Dose:  0.008
Skin Sensitization:  0.797
Carcinogencity:  0.124
Eye Corrosion:  0.003
Eye Irritation:  0.062
Respiratory Toxicity:  0.071

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC195257

Natural Product ID:  NPC195257
Common Name*:   Chrysoeriol-7-O-Neohesperidoside
IUPAC Name:   7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one
Synonyms:   Chrysoeriol 7-O-Neohesperidoside; Chrysoeriol 7-O-Neohesperidosyl
Standard InCHIKey:  LGOQXEQWOCSLEC-CYZBKYQRSA-N
Standard InCHI:  InChI=1S/C28H32O15/c1-10-21(33)23(35)25(37)27(39-10)43-26-24(36)22(34)19(9-29)42-28(26)40-12-6-14(31)20-15(32)8-16(41-18(20)7-12)11-3-4-13(30)17(5-11)38-2/h3-8,10,19,21-31,33-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27-,28+/m0/s1
SMILES:  OC[C@H]1O[C@@H](Oc2cc(O)c3c(c2)oc(cc3=O)c2ccc(c(c2)OC)O)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL447820
PubChem CID:   44593486
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22304 Morinda morindoides Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[12542353]
NPO22304 Morinda morindoides Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[20149652]
NPO22304 Morinda morindoides Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[7775983]
NPO33122 microtea debilis Species Microteaceae Eukaryota n.a. n.a. n.a. PMID[9214739]
NPO22304 Morinda morindoides Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1315 Individual Protein Adenosine A1 receptor Rattus norvegicus Activity = 94.0 % PMID[543137]
NPT967 Individual Protein Xanthine dehydrogenase Homo sapiens IC50 > 100000.0 nM PMID[543138]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[543138]
NPT2 Others Unspecified Activity = 11.2 % PMID[543139]
NPT2 Others Unspecified Activity = 4.6 % PMID[543139]
NPT992 Organism Entamoeba histolytica Entamoeba histolytica IC50 > 125.0 ug.mL-1 PMID[543140]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC195257 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC209296
0.9874 High Similarity NPC86008
0.9873 High Similarity NPC115674
0.9873 High Similarity NPC210073
0.9814 High Similarity NPC204693
0.9814 High Similarity NPC208668
0.9812 High Similarity NPC231194
0.9812 High Similarity NPC105095
0.9812 High Similarity NPC44328
0.9812 High Similarity NPC177731
0.9812 High Similarity NPC79056
0.9812 High Similarity NPC51326
0.981 High Similarity NPC22832
0.981 High Similarity NPC284277
0.981 High Similarity NPC311830
0.981 High Similarity NPC475497
0.981 High Similarity NPC475366
0.9753 High Similarity NPC16194
0.9753 High Similarity NPC220173
0.9753 High Similarity NPC19108
0.9753 High Similarity NPC476472
0.9753 High Similarity NPC294815
0.9753 High Similarity NPC198199
0.9753 High Similarity NPC473327
0.9752 High Similarity NPC180918
0.9752 High Similarity NPC256760
0.975 High Similarity NPC43587
0.975 High Similarity NPC293629
0.9748 High Similarity NPC236934
0.9748 High Similarity NPC8856
0.9748 High Similarity NPC5778
0.9747 High Similarity NPC222936
0.9747 High Similarity NPC309025
0.9747 High Similarity NPC270335
0.9747 High Similarity NPC243930
0.9747 High Similarity NPC19709
0.9747 High Similarity NPC284960
0.9747 High Similarity NPC88023
0.9747 High Similarity NPC191306
0.9689 High Similarity NPC67105
0.9689 High Similarity NPC95866
0.9689 High Similarity NPC285197
0.9689 High Similarity NPC150767
0.9689 High Similarity NPC78734
0.9688 High Similarity NPC229729
0.9686 High Similarity NPC15358
0.9684 High Similarity NPC189142
0.9684 High Similarity NPC473043
0.9684 High Similarity NPC77660
0.9634 High Similarity NPC89052
0.9634 High Similarity NPC173837
0.9634 High Similarity NPC120952
0.9634 High Similarity NPC251417
0.963 High Similarity NPC471725
0.963 High Similarity NPC3583
0.963 High Similarity NPC60735
0.963 High Similarity NPC134532
0.963 High Similarity NPC261254
0.963 High Similarity NPC155877
0.963 High Similarity NPC471748
0.963 High Similarity NPC259152
0.963 High Similarity NPC203259
0.963 High Similarity NPC176740
0.963 High Similarity NPC33054
0.963 High Similarity NPC26230
0.9627 High Similarity NPC219904
0.9627 High Similarity NPC229687
0.9627 High Similarity NPC223747
0.9627 High Similarity NPC226294
0.9627 High Similarity NPC227508
0.9627 High Similarity NPC120099
0.9627 High Similarity NPC58053
0.9627 High Similarity NPC475942
0.9627 High Similarity NPC45638
0.9627 High Similarity NPC105283
0.9627 High Similarity NPC186807
0.9627 High Similarity NPC93337
0.9627 High Similarity NPC225434
0.9627 High Similarity NPC469931
0.9627 High Similarity NPC201292
0.9627 High Similarity NPC203050
0.9627 High Similarity NPC105025
0.9625 High Similarity NPC197285
0.9625 High Similarity NPC21100
0.9623 High Similarity NPC29830
0.9623 High Similarity NPC168822
0.962 High Similarity NPC182045
0.9576 High Similarity NPC126784
0.9576 High Similarity NPC470444
0.9576 High Similarity NPC473571
0.9576 High Similarity NPC470443
0.9576 High Similarity NPC110941
0.9576 High Similarity NPC192539
0.9576 High Similarity NPC241423
0.9576 High Similarity NPC473682
0.9573 High Similarity NPC169733
0.9573 High Similarity NPC292019
0.9573 High Similarity NPC202908
0.9573 High Similarity NPC122467
0.9573 High Similarity NPC89127
0.9573 High Similarity NPC255799
0.9573 High Similarity NPC48984
0.9573 High Similarity NPC219043
0.9573 High Similarity NPC471669
0.9573 High Similarity NPC14187
0.9571 High Similarity NPC472993
0.9571 High Similarity NPC51774
0.9571 High Similarity NPC25724
0.9571 High Similarity NPC236191
0.9571 High Similarity NPC239549
0.9568 High Similarity NPC255157
0.9568 High Similarity NPC206123
0.9568 High Similarity NPC156869
0.9568 High Similarity NPC21190
0.9568 High Similarity NPC254855
0.9568 High Similarity NPC67326
0.9568 High Similarity NPC29958
0.9568 High Similarity NPC183357
0.9568 High Similarity NPC259896
0.9568 High Similarity NPC218488
0.9568 High Similarity NPC22195
0.9568 High Similarity NPC136042
0.9565 High Similarity NPC84362
0.9565 High Similarity NPC52550
0.9565 High Similarity NPC226304
0.9565 High Similarity NPC477502
0.9565 High Similarity NPC146792
0.9565 High Similarity NPC58716
0.9565 High Similarity NPC317489
0.9565 High Similarity NPC275454
0.9565 High Similarity NPC127546
0.9565 High Similarity NPC265530
0.9565 High Similarity NPC173637
0.9565 High Similarity NPC45400
0.9565 High Similarity NPC45618
0.9565 High Similarity NPC325555
0.9565 High Similarity NPC223424
0.9563 High Similarity NPC277205
0.956 High Similarity NPC300537
0.956 High Similarity NPC127782
0.9557 High Similarity NPC110349
0.9512 High Similarity NPC102028
0.9512 High Similarity NPC294629
0.9512 High Similarity NPC142996
0.9509 High Similarity NPC475155
0.9509 High Similarity NPC117260
0.9509 High Similarity NPC267254
0.9509 High Similarity NPC476405
0.9509 High Similarity NPC254540
0.9509 High Similarity NPC153755
0.9509 High Similarity NPC211594
0.9509 High Similarity NPC172807
0.9509 High Similarity NPC235575
0.9509 High Similarity NPC205076
0.9509 High Similarity NPC301683
0.9509 High Similarity NPC48773
0.9509 High Similarity NPC307518
0.9506 High Similarity NPC95855
0.9506 High Similarity NPC61791
0.9506 High Similarity NPC170675
0.9506 High Similarity NPC52382
0.9506 High Similarity NPC270578
0.9506 High Similarity NPC210042
0.9506 High Similarity NPC472381
0.9506 High Similarity NPC471457
0.9506 High Similarity NPC472383
0.9506 High Similarity NPC112755
0.9503 High Similarity NPC118284
0.9503 High Similarity NPC179950
0.9503 High Similarity NPC99957
0.9503 High Similarity NPC88789
0.9503 High Similarity NPC56077
0.9503 High Similarity NPC276222
0.9503 High Similarity NPC253662
0.9503 High Similarity NPC308404
0.9503 High Similarity NPC73855
0.9503 High Similarity NPC328940
0.9503 High Similarity NPC113968
0.9503 High Similarity NPC135599
0.9503 High Similarity NPC274618
0.9503 High Similarity NPC277174
0.9503 High Similarity NPC181616
0.9503 High Similarity NPC145038
0.9503 High Similarity NPC281131
0.95 High Similarity NPC88043
0.9494 High Similarity NPC138811
0.9494 High Similarity NPC22062
0.9494 High Similarity NPC473634
0.9461 High Similarity NPC470449
0.9461 High Similarity NPC470447
0.9461 High Similarity NPC470445
0.9461 High Similarity NPC470446
0.9461 High Similarity NPC473072
0.9458 High Similarity NPC471030
0.9455 High Similarity NPC473862
0.9455 High Similarity NPC65563
0.9455 High Similarity NPC8573
0.9455 High Similarity NPC470949
0.9451 High Similarity NPC101026
0.9451 High Similarity NPC42773

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC195257 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD7054 Approved
0.9937 High Similarity NPD7472 Approved
0.9812 High Similarity NPD7074 Phase 3
0.9691 High Similarity NPD7251 Discontinued
0.9632 High Similarity NPD7808 Phase 3
0.963 High Similarity NPD6797 Phase 2
0.9325 High Similarity NPD3818 Discontinued
0.9277 High Similarity NPD4338 Clinical (unspecified phase)
0.9202 High Similarity NPD6166 Phase 2
0.9202 High Similarity NPD6168 Clinical (unspecified phase)
0.9202 High Similarity NPD6167 Clinical (unspecified phase)
0.9187 High Similarity NPD4381 Clinical (unspecified phase)
0.9152 High Similarity NPD7804 Clinical (unspecified phase)
0.9057 High Similarity NPD1934 Approved
0.8882 High Similarity NPD2393 Clinical (unspecified phase)
0.8882 High Similarity NPD2801 Approved
0.8712 High Similarity NPD3817 Phase 2
0.8671 High Similarity NPD1511 Approved
0.858 High Similarity NPD4380 Phase 2
0.8562 High Similarity NPD1512 Approved
0.8545 High Similarity NPD4868 Clinical (unspecified phase)
0.8545 High Similarity NPD3882 Suspended
0.8439 Intermediate Similarity NPD6559 Discontinued
0.8383 Intermediate Similarity NPD7075 Discontinued
0.8382 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD5494 Approved
0.8232 Intermediate Similarity NPD1653 Approved
0.8208 Intermediate Similarity NPD7228 Approved
0.8204 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8155 Intermediate Similarity NPD5402 Approved
0.8155 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD6801 Discontinued
0.8129 Intermediate Similarity NPD6959 Discontinued
0.8125 Intermediate Similarity NPD1549 Phase 2
0.8125 Intermediate Similarity NPD7685 Pre-registration
0.8095 Intermediate Similarity NPD7819 Suspended
0.8095 Intermediate Similarity NPD1465 Phase 2
0.8061 Intermediate Similarity NPD5403 Approved
0.8057 Intermediate Similarity NPD5844 Phase 1
0.8046 Intermediate Similarity NPD7473 Discontinued
0.8034 Intermediate Similarity NPD8312 Approved
0.8034 Intermediate Similarity NPD8313 Approved
0.8022 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD2796 Approved
0.7988 Intermediate Similarity NPD6799 Approved
0.7977 Intermediate Similarity NPD6232 Discontinued
0.7976 Intermediate Similarity NPD7411 Suspended
0.7952 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD7266 Discontinued
0.7939 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD5401 Approved
0.7937 Intermediate Similarity NPD1510 Phase 2
0.7919 Intermediate Similarity NPD7199 Phase 2
0.7912 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD3751 Discontinued
0.7874 Intermediate Similarity NPD3787 Discontinued
0.7803 Intermediate Similarity NPD6234 Discontinued
0.7799 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD1613 Approved
0.7784 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD8455 Phase 2
0.7772 Intermediate Similarity NPD8151 Discontinued
0.776 Intermediate Similarity NPD7584 Approved
0.7747 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD7240 Approved
0.7719 Intermediate Similarity NPD37 Approved
0.7706 Intermediate Similarity NPD6599 Discontinued
0.7697 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD1240 Approved
0.7688 Intermediate Similarity NPD4965 Approved
0.7688 Intermediate Similarity NPD4967 Phase 2
0.7688 Intermediate Similarity NPD4966 Approved
0.7683 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1933 Approved
0.7632 Intermediate Similarity NPD6782 Approved
0.7632 Intermediate Similarity NPD6778 Approved
0.7632 Intermediate Similarity NPD6777 Approved
0.7632 Intermediate Similarity NPD6776 Approved
0.7632 Intermediate Similarity NPD6781 Approved
0.7632 Intermediate Similarity NPD6779 Approved
0.7632 Intermediate Similarity NPD6780 Approved
0.761 Intermediate Similarity NPD3027 Phase 3
0.7604 Intermediate Similarity NPD7696 Phase 3
0.7604 Intermediate Similarity NPD7698 Approved
0.7604 Intermediate Similarity NPD7697 Approved
0.7604 Intermediate Similarity NPD7435 Discontinued
0.7602 Intermediate Similarity NPD7783 Phase 2
0.7602 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD919 Approved
0.7593 Intermediate Similarity NPD1607 Approved
0.759 Intermediate Similarity NPD3750 Approved
0.7586 Intermediate Similarity NPD7768 Phase 2
0.7578 Intermediate Similarity NPD943 Approved
0.7562 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD7701 Phase 2
0.7531 Intermediate Similarity NPD230 Phase 1
0.7528 Intermediate Similarity NPD3926 Phase 2
0.7514 Intermediate Similarity NPD1247 Approved
0.7485 Intermediate Similarity NPD4628 Phase 3
0.7484 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD7871 Phase 2
0.7474 Intermediate Similarity NPD7870 Phase 2
0.7461 Intermediate Similarity NPD6823 Phase 2
0.7455 Intermediate Similarity NPD1551 Phase 2
0.7443 Intermediate Similarity NPD3749 Approved
0.744 Intermediate Similarity NPD6190 Approved
0.7435 Intermediate Similarity NPD7699 Phase 2
0.7435 Intermediate Similarity NPD7700 Phase 2
0.7423 Intermediate Similarity NPD447 Suspended
0.7396 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7874 Approved
0.7368 Intermediate Similarity NPD6535 Approved
0.7368 Intermediate Similarity NPD6534 Approved
0.736 Intermediate Similarity NPD7585 Approved
0.7358 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD2935 Discontinued
0.7341 Intermediate Similarity NPD7458 Discontinued
0.7337 Intermediate Similarity NPD7801 Approved
0.7333 Intermediate Similarity NPD7680 Approved
0.7321 Intermediate Similarity NPD6674 Discontinued
0.7321 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD2533 Approved
0.731 Intermediate Similarity NPD2534 Approved
0.731 Intermediate Similarity NPD2532 Approved
0.731 Intermediate Similarity NPD7583 Approved
0.7296 Intermediate Similarity NPD8319 Approved
0.7296 Intermediate Similarity NPD8320 Phase 1
0.7289 Intermediate Similarity NPD3748 Approved
0.7246 Intermediate Similarity NPD6099 Approved
0.7246 Intermediate Similarity NPD6100 Approved
0.7234 Intermediate Similarity NPD8150 Discontinued
0.7225 Intermediate Similarity NPD920 Approved
0.7222 Intermediate Similarity NPD6832 Phase 2
0.7219 Intermediate Similarity NPD2800 Approved
0.7216 Intermediate Similarity NPD6844 Discontinued
0.7215 Intermediate Similarity NPD1091 Approved
0.7209 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD5953 Discontinued
0.7188 Intermediate Similarity NPD4360 Phase 2
0.7188 Intermediate Similarity NPD4363 Phase 3
0.7186 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7033 Discontinued
0.7174 Intermediate Similarity NPD7286 Phase 2
0.7169 Intermediate Similarity NPD6651 Approved
0.716 Intermediate Similarity NPD9494 Approved
0.7151 Intermediate Similarity NPD7390 Discontinued
0.7143 Intermediate Similarity NPD8434 Phase 2
0.7143 Intermediate Similarity NPD3226 Approved
0.7135 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6212 Phase 3
0.7135 Intermediate Similarity NPD5353 Approved
0.7135 Intermediate Similarity NPD6213 Phase 3
0.7125 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD1652 Phase 2
0.7118 Intermediate Similarity NPD1243 Approved
0.7117 Intermediate Similarity NPD4908 Phase 1
0.711 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD2798 Approved
0.7093 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD1203 Approved
0.7033 Intermediate Similarity NPD8127 Discontinued
0.7033 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD2313 Discontinued
0.7019 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD6843 Phase 3
0.7016 Intermediate Similarity NPD6841 Approved
0.7016 Intermediate Similarity NPD6842 Approved
0.7006 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5124 Phase 1
0.7 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD2346 Discontinued
0.7 Intermediate Similarity NPD2344 Approved
0.6982 Remote Similarity NPD2799 Discontinued
0.6976 Remote Similarity NPD7930 Approved
0.6966 Remote Similarity NPD6386 Approved
0.6966 Remote Similarity NPD6385 Approved
0.6966 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6962 Remote Similarity NPD1548 Phase 1
0.6957 Remote Similarity NPD5242 Approved
0.6949 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6947 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6935 Remote Similarity NPD5005 Approved
0.6935 Remote Similarity NPD5006 Approved
0.6931 Remote Similarity NPD7549 Discontinued
0.6928 Remote Similarity NPD6798 Discontinued
0.6928 Remote Similarity NPD3268 Approved
0.6923 Remote Similarity NPD7097 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data